Alpha DNA Investment Management’s iShares Core MSCI EAFE ETF IEFA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-60
Closed -$4K 347
2021
Q1
$4K Sell
60
-523
-90% -$37.4K ﹤0.01% 410
2020
Q4
$40K Buy
+583
New +$37.7K 0.04% 196

Other funds holding IEFA

Alpha DNA Investment Management's IEFA Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of iShares Core MSCI EAFE ETF (IEFA) in Q2 2021, closing a stake of 60 shares — an estimated $4K sold.

Alpha DNA Investment Management first reported a position in IEFA in Q4 2020 and held it in 2 quarters. The position peaked at $40K in Q4 2020. 1,305 funds tracked by Wall St. Rank hold IEFA as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining iShares Core MSCI EAFE ETF position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 60 iShares Core MSCI EAFE ETF shares in Q2 2021, an estimated $4K.
  • Alpha DNA Investment Management first reported a position in iShares Core MSCI EAFE ETF in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's iShares Core MSCI EAFE ETF position peaked at $40K in Q4 2020.
  • 1,305 funds tracked by Wall St. Rank held iShares Core MSCI EAFE ETF as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.